Dai Nakashima

1.5k citations
49 papers · 1.2k indexed · h-index 22
Topics
Oral and Maxillofacial Pathology (9 papers)Cancer-related gene regulation (7 papers)RNA modifications and cancer (7 papers)

In The Last Decade

Dai Nakashima

48 papers receiving 1.1k citations

Peers

Dai Nakashima
Comparison fields: 5 of 89
  • Molecular Biology 832
  • Oncology 346
  • Cancer Research 328
  • Cell Biology 178
  • Immunology 145
Replace Morihiro Higo with:
Morihiro Higo Japan
Yukinao Kouzu Japan
Chad A. Glazer United States
Maher N. Younes United States
Yuanzheng Qiu China
Anne Cromer France
Alice Banh United States
Rajani Kanteti United States
Stephen B. Keysar United States
M. Phillip DeYoung United States
Dai Nakashima relative to Morihiro Higo Japan Morihiro Higo's profile →
Citations per field
00.5×1.5×1.9×
Morihiro Higo · 1×
Citations per year

Countries citing papers authored by Dai Nakashima

Since Specialization
Citations

This map shows the geographic impact of Dai Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Nakashima more than expected).

Fields of papers citing papers by Dai Nakashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Nakashima. The network helps show where Dai Nakashima may publish in the future.

Co-authorship network of co-authors of Dai Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Dai Nakashima. A scholar is included among the top collaborators of Dai Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dai Nakashima. Dai Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 45
2 4
3 14
4 22
5 30
6 16
7 17
8 29
9 17
10 20
11 66
12 1
13 5
14
Loss of heterozvgosity in oral cancer
0
15 66
16 80
17 21
18 23
19 18
20 23

About Dai Nakashima

Dai Nakashima is a scholar working on Oral Surgery, Cancer Research and Oncology, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Oral and Maxillofacial Pathology (9 papers), Cancer-related gene regulation (7 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (328 citations), Oncology (346 citations) and Otorhinolaryngology (53 citations). Dai Nakashima has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Hideki Tanzawa, Katsuhiro Uzawa, Atsushi Kasamatsu, Masashi Shiiba, Katsunori Ogawara, Morihiro Higo, Hirofumi Koike, Kazuki Saito, Hidetaka Yokoe and Yosuke Endo‐Sakamoto. Their work appears in journals such as PLoS ONE, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026